Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

The Lancet Oncology, 1470-2045

Tidsskrift

  1. 2020
  2. Udgivet

    Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J-L., De Giorgi, U., Bögemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suárez, C., Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., DANUBE study investigators & Pappot, H., dec. 2020, I: The Lancet Oncology. 21, 12, s. 1574-1588 15 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Udgivet

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply

    Subbiah, V., Lassen, U., Gasal, E., Burgess, P. & Wainberg, Z. A., nov. 2020, I: Lancet Oncology. 21, 11, s. e516

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. Udgivet

    Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

    Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P. & Wainberg, Z. A., sep. 2020, I: The Lancet Oncology. 21, 9, s. 1234-1243 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Udgivet

    Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

    Al-Sawaf, O., Zhang, C., Tandon, M., Sinha, A., Fink, A-M., Robrecht, S., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J., Tausch, E., Schary, W., Ritgen, M., Wendtner, C-M., Kreuzer, K-A., Eichhorst, B., Stilgenbauer, S., Hallek, M. & Fischer, K., sep. 2020, I: The Lancet Oncology. 21, 9, s. 1188-1200 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  6. Udgivet

    New approaches to cancer care in a COVID-19 world

    Butler, J., Finley, C., Norell, C. H., Harrison, S., Bryant, H., Achiam, M. P., Altman, A. D., Baxter, N., Bentley, J., Cohen, P. A., Chaudry, M. A., Dixon, E., Farrell, R., Fegan, S., Hashmi, S., Hogdall, C., Jenkins, J. T., Kwon, J., Mala, T., McNally, O., Merrett, N., Nelson, G., Nordin, A., Park, J., Porter, G., Reynolds, J., Schieman, C., Schnack, T., Spigelman, A., Svendsen, L. B., Sykes, P. & Thomas, R., jul. 2020, I: The Lancet Oncology. 21, 7, s. e339-e340

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  7. Udgivet

    Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Lassen, U., feb. 2020, I: Lancet Oncology. 21, 2, s. 193-194 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  8. Udgivet

    International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Devlin, N., Dorme, L., Flechtner, H-H., Gotay, C., Griebsch, I., Groenvold, M., King, M., Kluetz, P. G., Koller, M., Malone, D. C., Martinelli, F., Mitchell, S. A., Musoro, J. Z., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Quinten, C., Reijneveld, J. C., Schürmann, C., Smith, A. W., Soltys, K. M., Taphoorn, M. J. B., Velikova, G. & Bottomley, A., feb. 2020, I: The Lancet Oncology. 21, 2, s. e83-e96 14 s.

    Publikation: Bidrag til tidsskriftReviewpeer review

  9. 2019
  10. Udgivet
  11. Udgivet

    Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review

    Mierzynska, J., Piccinin, C., Pe, M., Martinelli, F., Gotay, C., Coens, C., Mauer, M., Eggermont, A., Groenvold, M., Bjordal, K., Reijneveld, J., Velikova, G. & Bottomley, A., dec. 2019, I: Lancet Oncology. 20, 12, s. e685-e698 14 s.

    Publikation: Bidrag til tidsskriftReviewpeer review

  12. Udgivet
  13. Udgivet

    Access to radiotherapy among circumpolar Inuit populations

    Chan, J., Friborg, J., Chernov, M., Cherkashin, M., Grau, C., Brundage, M. & Slotman, B., okt. 2019, I: Lancet Oncology. 20, 10, s. e590-e600

    Publikation: Bidrag til tidsskriftReviewpeer review

  14. Udgivet

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    AVANOVA investigators, okt. 2019, I: Lancet Oncology. 20, 10, s. 1409-1419 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  15. Udgivet

    Combining PARP inhibition with PD-1 inhibitors

    Lassen, U., sep. 2019, I: Lancet Oncology. 20, 9, s. 1196-1198 3 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  16. Udgivet

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, jun. 2019, I: Lancet Oncology. 20, 6, s. 862-876 15 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  17. Udgivet

    Meta-analysis of penile cancer: conceptual interpretations - Authors' reply

    Albieri, V., Olesen, T. B., Sand, F. L., Rasmussen, C. L., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., mar. 2019, I: Lancet Oncology. 20, 3, s. e126

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  18. Udgivet

    Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

    de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J-P., Arkenau, H-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., Ghatta, S., Slomovitz, B. M., Spicer, J. F., Yachnin, J., Ang, J. E., Mau-Sørensen, P. M., Forster, M. D., Collins, D., Dean, E., Rangwala, R. A. & Lassen, U., mar. 2019, I: Lancet Oncology. 20, 3, s. 383-393 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  19. Udgivet

    A European paediatric cancer mission: aspiration or reality?

    Kearns, P. R., Vassal, G., Ladenstein, R., Schrappe, M., Biondi, A., Blanc, P., Eggert, A., Kienesberger, A., Kozhaeva, O., Pieters, R. & Schmiegelow, K., 2019, I: Lancet Oncology. 20, 9, s. 1200-1202 3 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  20. Udgivet

    Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis

    Olesen, T. B., Sand, F. L., Rasmussen, C. L., Albieri, V., Toft, B. G., Norrild, B., Munk, C. & Kjær, S. K., 2019, I: Lancet Oncology. 20, 1, s. 145-158 14 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  21. Udgivet

    Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial

    Oscarsson, N., Müller, B., Rosén, A., Lodding, P., Mölne, J., Giglio, D., Hjelle, K. M., Vaagbø, G., Hyldegaard, O., Vangedal, M., Salling, L., Kjellberg, A., Lind, F., Ettala, O., Arola, O. & Seeman-Lodding, H., 2019, I: Lancet Oncology. 20, 11, s. 1602-1614 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  22. Udgivet

    Solid organ transplantations in childhood cancer survivors: an unrealised research potential

    Winther, J. F., Schmidt, I. M. & Poggio, E. D., 2019, I: Lancet Oncology. 20, 10, s. 1337-1338 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  23. 2018
  24. Udgivet

    Maternal use of hormonal contraception and risk of childhood leukaemia - Authors' reply

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., dec. 2018, I: Lancet Oncology. 19, 12, s. e659

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  25. Udgivet

    Integration of oncology and palliative care: a Lancet Oncology Commission

    Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., Deliens, L., Fallon, M., Gómez-Batiste, X., Grotmol, K. S., Hannon, B., Haugen, D. F., Higginson, I. J., Hjermstad, M. J., Hui, D., Jordan, K., Kurita, G. P., Larkin, P. J., Miccinesi, G., Nauck, F., Pribakovic, R., Rodin, G., Sjøgren, P., Stone, P., Zimmermann, C. & Lundeby, T., nov. 2018, I: Lancet Oncology. 19, 11, s. e588-e653

    Publikation: Bidrag til tidsskriftReviewpeer review

  26. Udgivet

    Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study

    Hargreave, M., Mørch, L. S., Andersen, K. K., Winther, J. F., Schmiegelow, K. & Kjaer, S. K., okt. 2018, I: Lancet Oncology. 19, 10, s. 1307-1314 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  27. Udgivet

    CCR4-targeted therapy in cutaneous T-cell lymphoma

    Gniadecki, R., sep. 2018, I: Lancet Oncology. 19, 9, s. 1140-1141 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  28. Udgivet

    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

    Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL), sep. 2018, I: Lancet Oncology. 19, 9, s. e459-e469 11 s.

    Publikation: Bidrag til tidsskriftReviewpeer review

  29. Udgivet

    Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

    Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., aug. 2018, I: Lancet Oncology. 19, 8, s. 1117-1125 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  30. Udgivet

    Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    Waszak, S. M., Northcott, P. A., Buchhalter, I., Robinson, G. W., Sutter, C., Groebner, S., Grund, K. B., Brugières, L., Jones, D. T. W., Pajtler, K. W., Morrissy, A. S., Kool, M., Sturm, D., Chavez, L., Ernst, A., Brabetz, S., Hain, M., Zichner, T., Segura-Wang, M., Weischenfeldt, J., Rausch, T., Mardin, B. R., Zhou, X., Baciu, C., Lawerenz, C., Chan, J. A., Varlet, P., Guerrini-Rousseau, L., Fults, D. W., Grajkowska, W., Hauser, P., Jabado, N., Ra, Y-S., Zitterbart, K., Shringarpure, S. S., De La Vega, F. M., Bustamante, C. D., Ng, H-K., Perry, A., MacDonald, T. J., Hernáiz Driever, P., Bendel, A. E., Bowers, D. C., McCowage, G., Chintagumpala, M. M., Cohn, R., Hassall, T., Fleischhack, G., Eggen, T., Wesenberg, F., Feychting, M., Lannering, B., Schüz, J., Johansen, C., Andersen, T. V., Röösli, M., Kuehni, C. E., Grotzer, M., Kjaerheim, K., Monoranu, C. M., Archer, T. C., Duke, E., Pomeroy, S. L., Shelagh, R., Frank, S., Sumerauer, D., Scheurlen, W., Ryzhova, M. V., Milde, T., Kratz, C. P., Samuel, D., Zhang, J., Solomon, D. A., Marra, M., Eils, R., Bartram, C. R., von Hoff, K., Rutkowski, S., Ramaswamy, V., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Malkin, D., Gajjar, A., Korbel, J. O. & Pfister, S. M., 1 jun. 2018, I: Lancet Oncology. 19, 6, s. 785-798

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  31. Udgivet

    Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    Colleoni, M., Luo, W., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Hitre, E., Graas, M-P., Simoncini, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O'Reilly, S., Di Lauro, V., Gombos, A., Ruhstaller, T., Burstein, H., Ribi, K., Bernhard, J., Viale, G., Maibach, R., Rabaglio-Poretti, M., Gelber, R. D., Coates, A. S., Di Leo, A., Regan, M. M., Goldhirsch, A. & SOLE Investigators, 2018, I: Lancet Oncology. 19, 1, s. 127-138

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  32. Udgivet

    Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database

    Brok, J., Lopez-Yurda, M., Tinteren, H. V., Treger, T. D., Furtwängler, R., Graf, N., Bergeron, C., van den Heuvel-Eibrink, M. M., Pritchard-Jones, K., Olsen, Ø. E., de Camargo, B., Verschuur, A. & Spreafico, F., 2018, I: Lancet Oncology. 19, 8, s. 1072-1081 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  33. 2017
  34. Udgivet

    European position statement on lung cancer screening

    Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., Baldwin, D. R., Callister, M. E., Becker, N., Heuvelmans, M. A., Rzyman, W., Infante, M. V., Pastorino, U., Pedersen, J. H., Paci, E., Duffy, S. W., de Koning, H. & Field, J. K., dec. 2017, I: Lancet Oncology. 18, 12, s. e754-e766

    Publikation: Bidrag til tidsskriftReviewpeer review

  35. Udgivet

    Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study

    Wolthers, B. O., Frandsen, T. L., Baruchel, A., Attarbaschi, A., Barzilai, S., Colombini, A., Escherich, G., Grell, K., Inaba, H., Kovacs, G., Liang, D-C., Mateos, M., Mondelaers, V., Möricke, A., Ociepa, T., Samarasinghe, S., Silverman, L. B., van der Sluis, I. M., Stanulla, M., Vrooman, L. M., Yano, M., Zapotocka, E., Schmiegelow, K. & Ponte di Legno Toxicity Working Group, sep. 2017, I: Lancet Oncology. 18, 9, s. 1238-1248 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  36. Udgivet

    Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., Schuetze, S., Reed, D., Chawla, S. P., Riedel, R. F., Krarup-Hansen, A., Toulmonde, M., Ray-Coquard, I., Hohenberger, P., Grignani, G., Cranmer, L. D., Okuno, S., Agulnik, M., Read, W., Ryan, C. W., Alcindor, T., Del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., aug. 2017, I: Lancet Oncology. 18, 8, s. 1089-1103 15 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  37. Udgivet

    Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? - Authors' reply

    Schmiegelow, K., Nielsen, S. N. & Grell, K., jun. 2017, I: Lancet Oncology. 18, 6, s. e292

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  38. Udgivet

    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

    Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J., Grange, F., Hoeller, C., Ferraresi, V., Smylie, M., Schadendorf, D., Mortier, L., Svane, I. M., Hennicken, D., Qureshi, A. & Maio, M., maj 2017, I: Lancet Oncology. 18, 5, s. 611-622 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  39. Udgivet

    DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

    Nielsen, S. N., Grell, K., Nersting, J., Abrahamsson, J., Lund, B., Kanerva, J., Jónsson, Ó. G., Vaitkeviciene, G., Pruunsild, K., Hjalgrim, L. L. & Schmiegelow, K., apr. 2017, I: Lancet Oncology. 18, 4, s. 515-524 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  40. Udgivet

    The drama of prostate cancer diagnostics - Authors' reply

    Iversen, P., Røder, M. A. & Klemann, N., mar. 2017, I: Lancet Oncology. 18, 3, s. e133

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  41. Udgivet
  42. Udgivet

    Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Martin, M., Holmes, F. A., Ejlertsen, B., Delaloge, S., Moy, B., Iwata, H., von Minckwitz, G., Chia, S. K. L., Mansi, J., Barrios, C. H., Gnant, M., Tomašević, Z., Denduluri, N., Šeparović, R., Gokmen, E., Bashford, A., Ruiz Borrego, M., Kim, S-B., Jakobsen, E. H., Ciceniene, A., Inoue, K., Overkamp, F., Heijns, J. B., Armstrong, A. C., Link, J. S., Joy, A. A., Bryce, R., Wong, A., Moran, S., Yao, B., Xu, F., Auerbach, A., Buyse, M., Chan, A. & ExteNET Study Group, 2017, I: Lancet Oncology. 18, 12, s. 1688-1700

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  43. 2016
  44. Udgivet

    Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

    Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Dueck, A. C., Devlin, N., Flechtner, H-H., Gotay, C., Greimel, E., Griebsch, I., Groenvold, M., Hamel, J-F., King, M., Kluetz, P. G., Koller, M., Malone, D. C., Martinelli, F., Mitchell, S. A., Moinpour, C. M., Musoro, J., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Pimentel, F. L., Quinten, C., Reijneveld, J. C., Schürmann, C., Smith, A. W., Soltys, K. M., Taphoorn, M. J. B., Velikova, G., Coens, C. & Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium, nov. 2016, I: Lancet Oncology. 17, 11, s. e510-e514 5 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  45. Udgivet

    Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus

    Schmiegelow, K., Attarbaschi, A., Barzilai, S., Escherich, G., Frandsen, T. L., Halsey, C., Hough, R., Jeha, S., Kato, M., Liang, D-C., Mikkelsen, T. S., Möricke, A., Niinimäki, R., Piette, C., Putti, M. C., Raetz, E., Silverman, L. B., Skinner, R., Tuckuviene, R., van der Sluis, I., Zapotocka, E. & Ponte di Legno toxicity working group, jun. 2016, I: Lancet Oncology. 17, 6, s. e231-9

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  46. Udgivet

    Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

    O'Sullivan, B., Huang, S. H., Su, J., Garden, A. S., Sturgis, E. M., Dahlstrom, K., Lee, N., Riaz, N., Pei, X., Koyfman, S. A., Adelstein, D., Burkey, B. B., Friborg, J., Kristensen, C. A., Gothelf, A. B., Hoebers, F., Kremer, B., Speel, E-J., Bowles, D. W., Raben, D., Karam, S. D., Yu, E. & Xu, W., apr. 2016, I: Lancet Oncology. 17, 4, s. 440-51 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  47. Udgivet

    Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Chan, A., Delaloge, S., Holmes, F. A., Moy, B., Iwata, H., Harvey, V. J., Robert, N. J., Silovski, T., Gokmen, E., von Minckwitz, G., Ejlertsen, B., Chia, S. K. L., Mansi, J., Barrios, C. H., Gnant, M., Buyse, M., Gore, I., Smith, J., Harker, G., Masuda, N., Petrakova, K., Zotano, A. G., Iannotti, N., Rodriguez, G., Tassone, P., Wong, A., Bryce, R., Ye, Y., Yao, B., Martin, M. & ExteNET Study Group, mar. 2016, I: Lancet Oncology. 17, 3, s. 367-77 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  48. Udgivet

    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

    Bois, A. D., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G., Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium, jan. 2016, I: Lancet Oncology. 17, 1, s. 78–89

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  49. 2015
  50. Udgivet

    Classification of treatment-related mortality in children with cancer: a systematic assessment

    Alexander, S., Pole, J. D., Gibson, P., Lee, M., Hesser, T., Chi, S. N., Dvorak, C. C., Fisher, B., Hasle, H., Kanerva, J., Möricke, A., Phillips, B., Raetz, E., Rodriguez-Galindo, C., Samarasinghe, S., Schmiegelow, K., Tissing, W., Lehrnbecher, T., Sung, L. & International Pediatric Oncology Mortality Classification Group, dec. 2015, I: Lancet Oncology. 16, 16, s. e604-10

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  51. Udgivet

    Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

    Soria, J-C., Felip, E., Cobo, M., Lu, S., Syrigos, K., Lee, K. H., Göker, E., Georgoulias, V., Li, W., Isla, D., Guclu, S. Z., Morabito, A., Min, Y. J., Ardizzoni, A., Gadgeel, S. M., Wang, B., Chand, V. K., Goss, G. D. & LUX-Lung 8 Investigators (Anders Mellemgaard, members), aug. 2015, I: Lancet Oncology. 16, 8, s. 897-907 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  52. Udgivet

    High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study

    Appelt, A. L., Pløen, J., Harling, H., Jensen, F. S., Jensen, L. H., Jørgensen, J., Lindebjerg, J., Rafaelsen, S. R. & Jakobsen, A., aug. 2015, I: Lancet Oncology. 16, 8, s. 919-27 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  53. Udgivet

    Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

    Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M., Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, aug. 2015, I: Lancet Oncology. 16, 8, s. 928-36 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  54. Udgivet

    Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

    Machiels, J-P. H., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Vermorken, J. B., Clement, P. M., Gauler, T. C., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., Del Campo, J. M., Cong, X. J., Ehrnrooth, E., Cohen, E. E. W., LUX-H&N 1 investigators (Lena Specht, member) & Specht, L., maj 2015, I: Lancet Oncology. 16, 5, s. 583-94 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  55. Udgivet

    Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

    Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., Linette, G. P., Thomas, L., Lorigan, P., Grossmann, K. F., Hassel, J. C., Maio, M., Sznol, M., Ascierto, P. A., Mohr, P., Chmielowski, B., Bryce, A., Svane, I. M., Grob, J-J., Krackhardt, A. M., Horak, C., Lambert, A., Yang, A. S. & Larkin, J., apr. 2015, I: Lancet Oncology. 16, 4, s. 375-84 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  56. Udgivet

    Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

    Farooqui, M. Z. H., Valdez, J., Martyr, S., Aue, G., Saba, N., Niemann, C. U., Herman, S. E. M., Tian, X., Marti, G., Soto, S., Hughes, T. E., Jones, J., Lipsky, A., Pittaluga, S., Stetler-Stevenson, M., Yuan, C., Lee, Y. S., Pedersen, L. B., Geisler, C. H., Calvo, K. R., Arthur, D. C., Maric, I., Childs, R., Young, N. S. & Wiestner, A., feb. 2015, I: Lancet Oncology. 16, 2, s. 169-76 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Forrige 1 2 Næste

ID: 109280